1. GlaxoSmithKline offload rare disease gene therapies to orchard therapeutics;Al Idrus;Fierce Biotech,2018
2. Antigen specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors;Alvarez-Vallina;Eur J Immunol,1996
3. PRIME - PRIority MEdicines;Anonymous,2016
4. The cancer immunotherapy market will capture major-market sales of over $13 billion in 2023 and will be dominated by immune checkpoint inhibitors;Anonymous,2015
5. The cancer drugs & treatments market - data, analysis & forecasts to 2023;Anonymous;GMR Data,2013